RxDoctor Payments Data

Antonio Wong, MD

Family Medicine · Pembroke Pines, FLNPI 1164460937

Payments from drug & device makers

$6,794in general payments, 2019–2025

Across 106 payments — averaging $64.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$5K
  • Sanofi-aventis U.S. LLC$358
  • Optinose US, Inc.$249
  • Lilly USA, LLC$205
  • Amgen$153
  • GSK$133
  • plus $893 from 18 others

What the payments were for

  • Consulting fees$3,86357%
  • Travel & lodging$100%
  • Food & beverage$2,92243%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,794 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$39,836
Medicare patients
88
Services billed
471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate64$72,238
EliquisApixaban59$57,422
JardianceEmpagliflozin27$41,057
JanumetSitagliptin Phos/Metformin Hcl29$40,551
OzempicSemaglutide27$34,744
FarxigaDapagliflozin Propanediol18$29,654
TradjentaLinagliptin20$29,580
XareltoRivaroxaban21$25,747
LinzessLinaclotide14$12,447
Tresiba Flextouch U-200Insulin Degludec14$11,801
Lantus SolostarInsulin Glargine,hum.Rec.Anlog50$7,663
Atorvastatin Calcium649$5,580
Losartan Potassium502$4,763
SymbicortBudesonide/Formoterol Fumarate11$3,912
Nano 2nd Gen Pen NeedlePen Needle, Diabetic41$3,461

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$18$112,78993 claims
Boehringer IngelheimJardiance, Tradjenta$49$70,63747 claims
PfizerEliquis$57$57,42259 claims
Novo NordiskOzempic$4,801$34,74427 claims
AstraZenecaFarxiga, Symbicort$73$33,56629 claims
Johnson & JohnsonXarelto$77$25,74721 claims
AbbVieLinzess, Synthroid$118$14,46335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →